Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Platelet-activating factor acether (PAF-acether) involvement in acute inflammatory and pain processes

J Bonnet, A M Loiseau, M Orvoen

    Agents and Actions
    |December 1, 1981
    PubMed
    Summary

    Platelet-activating factor-acether (PAF-acether) causes significant inflammation and hyperalgesia in rats. Certain drugs, like PGI2 and imidazole, can reduce PAF-acether-induced hyperalgesia, showing a dissociation between inflammation and pain responses.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Insights Into School-Based Physical Activity Implementation Strategies During the COVID-19 Pandemic: A Thematic Analysis.

    Child: care, health and development·2025
    Same author

    [Sleeping Sickness: A Cause of False Positive HIV Rapid Diagnostic Tests].

    Medecine tropicale et sante internationale·2022
    Same author

    Nascent teichoic acids insertion into the cell wall directs the localization and activity of the major pneumococcal autolysin LytA.

    Cell surface (Amsterdam, Netherlands)·2020
    Same author

    Specific and spatial labeling of choline-containing teichoic acids in Streptococcus pneumoniae by click chemistry.

    Chemical communications (Cambridge, England)·2017
    Same author

    Autocatalytic association of proteins by covalent bond formation: a Bio Molecular Welding toolbox derived from a bacterial adhesin.

    Scientific reports·2017
    Same author

    Ankle brachial index using an automatic blood pressure device in occupational medicine: relevance in routine examination and comparison with Framingham cardio-vascular risk score.

    International journal of clinical practice·2012

    Area of Science:

    • Pharmacology
    • Inflammation Research
    • Pain Management

    Background:

    • Platelet-activating factor-acether (PAF-acether) is a key mediator in acute inflammatory processes.
    • Understanding PAF-acether's role in generating inflammation and hyperalgesia is crucial for developing targeted therapies.

    Purpose of the Study:

    • To investigate the pro-inflammatory and hyperalgesic effects of exogenous PAF-acether in a rat model.
    • To evaluate the efficacy of various drugs in modulating PAF-acether-induced edema and hyperalgesia.

    Main Methods:

    • Subplantar injection of PAF-acether in rat paws to induce edema (measured by plethysmometry) and hyperalgesia (Randall-Sellito test).
    • Dose-response and time-course studies for PAF-acether effects.
    • Assessment of drug interactions with PAF-acether-induced responses, including comparison with kaolin-induced edema.

    Related Experiment Videos

    Main Results:

    • PAF-acether induced dose-dependent edema and hyperalgesia, both long-lasting.
    • PAF-acether was more potent than PGI2 and PGE2 in inducing edema, pain, and increasing vascular permeability.
    • Non-steroidal anti-inflammatory drugs (NSAIDs) had minimal effect on hyperalgesia.
    • Several agents, including prednisolone and PGI2, reduced edema, potentially via increased cyclic AMP levels.
    • PGI2 and imidazole were effective in improving PAF-acether-induced hyperalgesia, demonstrating a dissociation between edema and pain modulation.

    Conclusions:

    • PAF-acether is a potent inducer of inflammation and hyperalgesia with distinct characteristics from other mediators.
    • Drug responses highlight a dissociation between PAF-acether-induced edema and hyperalgesia, suggesting different therapeutic targets.
    • Further research into agents like PGI2 and imidazole may offer novel strategies for managing pain associated with inflammation.